TBG Inc., the subsidiary of Medigen Biotechnology, owned 51.76% stake of TBG Diagnostics Limited (formerly Progen Pharmaceuticals Limited) after stock swap. TBG Diagnostics Limited (TDL) is now listed on Australian Securities Exchange (ASX) as of February 3, 2016. 

Related news (in Chinese): 
1.Yahoo Stock